MedTrace Logo

Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients

NCT01170247 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-07-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.

Conditions

  • Sedation

Interventions

DRUG

Ketamine

Intranasal Ketamine (100 mg/mL)

DRUG

Ketamine

Intramuscular Ketamine

Sponsors & Collaborators

  • University of Iowa

    lead OTHER

Principal Investigators

  • Christopher Hogrefe, MD · University of Iowa

  • Brett Faine, Pharm.D. · University of Iowa

  • Andrew Nugent, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01170247 on ClinicalTrials.gov